StockData
Haemonetics Corp logo

Haemonetics Corp (HAE) stock

HAENYSESurgical & Medical Instruments & ApparatusFiscal year ends April 3
Financials through Q1 FY2027, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3077% above fair value
$122.86+1.94 (+1.60%)

Close on Nov 18, 2026Market cap $5.59BP/E 59.9Yield –

Haemonetics net income

Net income is the profit left for shareholders after every expense, interest and tax.

Haemonetics's net income for the twelve months ending Jun 27, 2026 was $96.29M, down 41.1% year over year. For fiscal 2026 it was $97.31M, down 42.0% from the year before. The highest annual figure on record is $167.68M in fiscal 2025.

Annual net income

PeriodPeriod endValueChange
FY2026Mar 28, 2026$97.31M-42.0%
FY2025Mar 29, 2025$167.68M+42.6%
FY2024Mar 30, 2024$117.56M+1.9%
FY2023Apr 1, 2023$115.40M+166.1%
FY2022Apr 2, 2022$43.38M-45.4%
FY2021Apr 3, 2021$79.47M+3.8%
FY2020Mar 28, 2020$76.53M+39.1%
FY2019Mar 30, 2019$55.02M+20.7%
FY2018Mar 31, 2018$45.57M–
FY2017Apr 1, 2017-$26.27M–
FY2016Apr 2, 2016-$55.58M-428.9%
FY2015Mar 28, 2015$16.90M-51.9%
FY2014Mar 29, 2014$35.15M-9.4%
FY2013Mar 30, 2013$38.80M-42.0%
FY2012Mar 31, 2012$66.89M-16.4%
FY2011Apr 2, 2011$79.98M+37.0%
FY2010Apr 3, 2010$58.37M-1.6%
FY2009Mar 28, 2009$59.30M–

Quarterly net income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jun 27, 2026$33.01M-3.0%
Q4 FY2026CQ1 2026Mar 28, 2026-$20.15M-134.7%
Q3 FY2026CQ4 2025Dec 27, 2025$44.74M+19.3%
Q2 FY2026CQ3 2025Sep 27, 2025$38.68M+14.3%
Q1 FY2026CQ2 2025Jun 28, 2025$34.03M-11.3%
Q4 FY2025CQ1 2025Mar 29, 2025$57.98M+184.7%
Q3 FY2025CQ4 2024Dec 28, 2024$37.49M+20.0%
Q2 FY2025CQ3 2024Sep 28, 2024$33.83M+35.8%
Q1 FY2025CQ2 2024Jun 29, 2024$38.37M-6.5%
Q4 FY2024CQ1 2024Mar 30, 2024$20.37M-30.7%
Q3 FY2024CQ4 2023Dec 30, 2023$31.24M-5.2%
Q2 FY2024CQ3 2023Sep 30, 2023$24.91M-25.0%
Q1 FY2024CQ2 2023Jul 1, 2023$41.04M+106.5%
Q4 FY2023CQ1 2023Apr 1, 2023$29.38M+201.6%
Q3 FY2023CQ4 2022Dec 31, 2022$32.94M+41.8%
Q2 FY2023CQ3 2022Oct 1, 2022$33.20M+123.5%
Q1 FY2023CQ2 2022Jul 2, 2022$19.88M–
Q4 FY2022CQ1 2022Apr 2, 2022$9.74M–
Q3 FY2022CQ4 2021Jan 1, 2022$23.23M-27.1%
Q2 FY2022CQ3 2021Oct 2, 2021$14.86M-69.1%
Q1 FY2022CQ2 2021Jul 3, 2021-$4.45M-142.3%
Q4 FY2021CQ1 2021Apr 3, 2021-$11.04M-162.6%
Q3 FY2021CQ4 2020Dec 26, 2020$31.88M+6.6%
Q2 FY2021CQ3 2020Sep 26, 2020$48.10M+28.3%
Q1 FY2021CQ2 2020Jun 27, 2020$10.53M–
Q4 FY2020CQ1 2020Mar 28, 2020$17.62M-15.4%
Q3 FY2020CQ4 2019Dec 28, 2019$29.90M–
Q2 FY2020CQ3 2019Sep 28, 2019$37.49M+100.2%
Q1 FY2020CQ2 2019Jun 29, 2019-$8.48M–
Q4 FY2019CQ1 2019Mar 30, 2019$20.84M+75.4%
Q3 FY2019CQ4 2018Dec 29, 2018-$8.48M–
Q2 FY2019CQ3 2018Sep 29, 2018$18.73M-6.8%
Q1 FY2019CQ2 2018Jun 30, 2018-$2.82M-114.0%
Q4 FY2018CQ1 2018Mar 31, 2018$11.88M–
Q3 FY2018CQ4 2017Dec 30, 2017-$6.55M-142.5%
Q2 FY2018CQ3 2017Sep 30, 2017$20.10M+1.4%
Q1 FY2018CQ2 2017Jul 1, 2017$20.14M–
Q4 FY2017CQ1 2017Apr 1, 2017-$51.14M–
Q3 FY2017CQ4 2016Dec 31, 2016$15.39M–
Q2 FY2017CQ3 2016Oct 1, 2016$19.83M–

More Haemonetics figures

See a number that looks wrong?